Parkinson Disease
- PMID: 30178019
- DOI: 10.7326/AITC201809040
Parkinson Disease
Abstract
Parkinson disease is a common neurodegenerative disorder that causes progressive motor and nonmotor disability. It is diagnosed clinically and requires a detailed history and neurologic examination to exclude alternative diagnoses. Although disease-modifying therapies do not exist for Parkinson disease, effective symptomatic therapies, including dopaminergic medications and surgery, allow patients to maintain good quality of life for many years. Nonmotor symptoms, including mood, cognitive, sleep, autonomic, and gastrointestinal symptoms, should be managed by a multidisciplinary team of clinicians. Recent advances include new diagnostic criteria from the Movement Disorder Society and the addition of new symptomatic therapies for treating motor complications and nonmotor symptoms in advanced disease.
Similar articles
-
The impact and management of nonmotor symptoms of Parkinson's disease.Am J Manag Care. 2011 Oct;17 Suppl 12:S308-14. Am J Manag Care. 2011. PMID: 22087551 Review.
-
Diagnosis and Treatment of Parkinson Disease: A Review.JAMA. 2020 Feb 11;323(6):548-560. doi: 10.1001/jama.2019.22360. JAMA. 2020. PMID: 32044947 Review.
-
The hidden sister of motor fluctuations in Parkinson's disease: A review on nonmotor fluctuations.Mov Disord. 2016 Aug;31(8):1080-94. doi: 10.1002/mds.26731. Epub 2016 Jul 19. Mov Disord. 2016. PMID: 27431515 Review.
-
Treatment of Nonmotor Symptoms in Parkinson's Disease.Int Rev Neurobiol. 2017;132:361-379. doi: 10.1016/bs.irn.2017.03.002. Epub 2017 May 3. Int Rev Neurobiol. 2017. PMID: 28554415 Review.
-
Pharmacological treatment of Parkinson disease: a review.JAMA. 2014 Apr 23-30;311(16):1670-83. doi: 10.1001/jama.2014.3654. JAMA. 2014. PMID: 24756517 Review.
Cited by
-
Investigation of total cerebellar and flocculonodular lobe volume in Parkinson's disease and healthy individuals: a brain segmentation study.Neurol Sci. 2024 Sep;45(9):4291-4298. doi: 10.1007/s10072-024-07509-5. Epub 2024 Apr 16. Neurol Sci. 2024. PMID: 38622454 Free PMC article.
-
Social isolation and the risk of Parkinson disease in the UK biobank study.NPJ Parkinsons Dis. 2024 Apr 8;10(1):79. doi: 10.1038/s41531-024-00700-7. NPJ Parkinsons Dis. 2024. PMID: 38589402 Free PMC article.
-
Sodium butyrate activates the KATP channels to regulate the mechanism of Parkinson's disease microglia model inflammation.Immun Inflamm Dis. 2024 Mar;12(3):e1194. doi: 10.1002/iid3.1194. Immun Inflamm Dis. 2024. PMID: 38501544 Free PMC article.
-
Linalool, a Fragrance Compound in Plants, Protects Dopaminergic Neurons and Improves Motor Function and Skeletal Muscle Strength in Experimental Models of Parkinson's Disease.Int J Mol Sci. 2024 Feb 21;25(5):2514. doi: 10.3390/ijms25052514. Int J Mol Sci. 2024. PMID: 38473763 Free PMC article.
-
Knowledge, attitude, and practice of healthcare professionals toward cognitive dysfunction in Parkinson's disease and cognitive rehabilitation.BMC Med Educ. 2024 Jan 4;24(1):26. doi: 10.1186/s12909-023-04989-5. BMC Med Educ. 2024. PMID: 38178059 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical